sevelamer hydrochloride tablet, film coated
american health packaging - sevelamer hydrochloride (unii: gls2pgi8qg) (sevelamer - unii:941n5duu5c) - sevelamer hydrochloride tablets are indicated for the control of serum phosphorus in patients with chronic kidney disease (ckd) on dialysis. the safety and efficacy of sevelamer hydrochloride tablets in ckd patients who are not on dialysis have not been studied. sevelamer hydrochloride is contraindicated in patients with bowel obstruction. sevelamer hydrochloride tablets are contraindicated in patients with known hypersensitivity to sevelamer hydrochloride or to any of the excipients. risk summary sevelamer hydrochloride is not absorbed systemically following oral administration and maternal use is not expected to result in fetal exposure to the drug. clinical considerations sevelamer hydrochloride may decrease serum levels of fat soluble vitamins and folic acid in pregnant women [see clinical pharmacology ( 12.2)]. consider supplementing with these vitamins. data animal data in pregnant rats given dietary doses of 0.5, 1.5, or 4.5 g/kg/day of sevelamer hydrochloride during organog
sevelamer hydrochloride tablet, film coated
northstar rxllc - sevelamer hydrochloride (unii: gls2pgi8qg) (sevelamer - unii:941n5duu5c) - sevelamer hydrochloride tablets are indicated for the control of serum phosphorus in patients with chronic kidney disease (ckd) on dialysis. the safety and efficacy of sevelamer hydrochloride tablets in ckd patients who are not on dialysis have not been studied. sevelamer hydrochloride is contraindicated in patients with bowel obstruction. sevelamer hydrochloride tablets are contraindicated in patients with known hypersensitivity to sevelamer hydrochloride or to any of the excipients. risk summary sevelamer hydrochloride is not absorbed systemically following oral administration and maternal use is not expected to result in fetal exposure to the drug. clinical considerations sevelamer hydrochloride may decrease serum levels of fat soluble vitamins and folic acid in pregnant women [ see clinical pharmacology (12.2)] . consider supplementing with these vitamins. data animal data in pregnant rats given dietary doses of 0.5, 1.5, or 4.5 g/kg/day of sevelamer hydrochloride during organogenesis, reduced or irregula
sevelamer hydrochloride tablet, film coated
macleods pharmaceuticals limited - sevelamer hydrochloride (unii: gls2pgi8qg) (sevelamer - unii:941n5duu5c) - sevelamer hydrochloride tablets are indicated for the control of serum phosphorus in patients with chronic kidney disease (ckd) on dialysis. the safety and efficacy of sevelamer hydrochloride tablets in ckd patients who are not on dialysis have not been studied. sevelamer hydrochloride tablets are contraindicated in patients with bowel obstruction. sevelamer hydrochloride tablets are contraindicated in patients with known hypersensitivity to sevelamer hydrochloride or to any of the excipients. risk summary sevelamer hydrochloride is not absorbed systemically following oral administration and maternal use is not expected to result in fetal exposure to the drug. clinical considerations sevelamer hydrochloride may decrease serum levels of fat soluble vitamins and folic acid in pregnant women [see clinical pharmacology (12.2)]. consider supplementing with these vitamins. data animal data in pregnant rats given dietary doses of 0.5, 1.5, or 4.5 g/kg/day of sevelamer hydrochloride during organogenesis, reduced or
sevelamer hydrochloride winthrop sevelamer hydrochloride 800 mg tablet bottle
sanofi-aventis australia pty ltd - sevelamer hydrochloride -
sevelamer hydrochloride winthrop sevelamer hydrochloride 400 mg tablet bottle
sanofi-aventis australia pty ltd - sevelamer hydrochloride -
sevelamer hydrochloride sanofi sevelamer hydrochloride 800 mg tablet bottle
sanofi-aventis australia pty ltd - sevelamer hydrochloride -
sevelamer hydrochloride sanofi sevelamer hydrochloride 400 mg tablet bottle
sanofi-aventis australia pty ltd - sevelamer hydrochloride -
sevelamer-carbonaat genthon 800 mg film-coat. tabl.
genthon b.v. - sevelamer 800 mg - film-coated tablet - 800 mg - sevelamer carbonate 800 mg - sevelamer
accel-sevelamer tablet
accel pharma inc - sevelamer carbonate - tablet - 800mg - sevelamer carbonate 800mg - phosphate-removing agents
intelli-sevelamer tablet
intellipharm inc - sevelamer carbonate - tablet - 800mg - sevelamer carbonate 800mg - phosphate-removing agents